Abstract
The first essential step in TNF signal transduction is believed to be clustering of the membrane bound receptors around the trimeric TNF molecule. To check if one receptor binding site would be enough to trigger the signal, we tried to prepare several types of TNF dimer. For this purpose, two TNF analogs bearing different cysteine mutations at the inner subunit binding surfaces were designed, expressed in E. coli and prepared in pure form. By mixing equimolar quantities of these analogs under appropriate conditions, two different types of dimer were prepared. The first, Dim/S2, proved to be composed mainly of a disulfide-linked dimer, which was still capable of trapping the third subunit of either of the precursor analogs, thus showing relatively high residual cytotoxicity. To avoid trimeric structures, Dim/S2 was further transformed into Dim/Iaa2 by alkylation of -SH groups of the newly introduced cysteines, allowing binding of only two TNF subunits through native contact surfaces. These dimers showed substantially reduced cytotoxicity on the L929 cell line. In addition, it appears that Dim/Iaa2 is able to competitively inhibit cytotoxicity of native TNF, as assessed on the L-M cell line.
References
Alzani R, Cozzi E, Corti A, Temponi M, Trizio D, Gigli M, Rizzo V (1995) Mechanism of suramin-induced deoligomerization of tumor necrosis factor alpha. Biochemistry 34:6344–6350
Bazzoni F, Beutler B (1996) The tumor necrosis factor ligand and receptor families. The New England Journal of Medicine 334:1717–1725
Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc.Natl.Acad.Sci.USA 72:3666–3670
Hlodan R, Pain RH (1995) The folding and assembly pathway of tumour necrosis factor TNF alpha, a globular trimeric protein. Eur. J. Biochem. 231:381–387
Meager A, Gaines Das RE (1994) International collaborative study of the candidate international standards for human tumour necrosis factor alpha (hTNF-a) and beta (hTNF-b) and for murine tumour necrosis factor alpha (mTNF-a). J.Immunol.Methods 170:1–13
Meager A, Leung H, Wooley J (1989) Assays for tumour necrosis factor and related cytokines. J.Immunol.Methods 116:1–17
Menart V, Gaberc-Porekar V, Harb V (1994) Metal-affinity separation of model proteins having differently spaced clusters of histidine residues. In: Pyle, D. L. (ed.) Separations for Biotechnology 3, The Royal Society of Chemistry, Cambridge, pp 308–313
Saijo S, Watanabe N, Kobayashi Y (1995) Comparison of reactivity of monoclonal antibody (3F2) to trimeric tumor necrosis factor (TNF-α) with that to monomelic TNF-alpha. J.Biochem.Tokyo. 118:28–32
Smith RA, Baglioni C (1987) The active form of tumor necrosis factor is a trimer. J. Biol. Chem. 262:6951–6954
VanOstade X, Tavernier J, Fiers W (1994) Structure-activity studies of human tumour necrosis factors. Protein Eng. 7:5–22
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Menart, V., Gaberc-Porekar, V., Jevševar, S. et al. Early events in TNFa — p55 receptor interactions — experiments with TNF dimers. Pflugers Arch — Eur J Physiol 439, R113–R115 (2000). https://doi.org/10.1007/BF03376541
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03376541